Open AccessDownregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide
Author(s) -
Huihan Wang,
Hua Shi,
Xiayun He,
Aijun Liao
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s300328
Subject(s) - lenalidomide , multiple myeloma , ccl20 , cancer research , medicine , chemokine , immunology , immune system , chemokine receptor
Few studies have focused on investigating resistance mechanisms in myeloma immunotherapy. This study aimed to explore the relevant factor involved in the resistance of Elotuzumab and lenalidomide.